-
Featured ArticleJuly 10, 2023Rueter and Rosenthal to headline 2023 Forum for Discovery
Harnessing genetics to understand personalized cancer care and regenerative medicine. -
Blog PostMay 04, 2023Advancing cancer research with the latest therapies
Improving cancer patient outcomes depends on expanding our understanding of basic cancer biology as well as improving patient access to the latest therapies. -
Press ReleaseDecember 19, 2022An outstanding year of growth at The Jackson Laboratory
2022 has been a notable year for The Jackson Laboratory, with great achievements and many reasons to celebrate continued momentum for JAX’s mission. -
Featured ArticleSeptember 15, 2022JAX undertakes nationwide study to evaluate impact of genomic tumor boards on cancer care
The Jackson Laboratory announced today that it will take its cornerstone genomic tumor board program to oncologists across the nation as part of a SWOG Cancer Research Network study, in collaboration with Columbia University.
-
Featured ArticleJune 14, 2023Bringing precision cancer care to Maine patients
Examining how MCGI has dramatically improved cancer care in Maine, from its inception in 2016 to today. -
Blog PostJanuary 09, 2023MCGI: Meet the team
Learn more about the JAX MCGI team, including roles and fun facts. -
Press ReleaseOctober 24, 2022JAX participates in A Day of Hope for Maines cancer fighters
Eight team members who make up JAX's MCGI recently attended MaineGeneral's annual Day of Hope Event at the Augusta Civic Center. -
Featured ArticleJune 28, 2022JAX Genomic Medicine is increasing the precision of brain cancer diagnoses
The new technique of methylome profiling, now available from The Jackson Laboratory, provides more precise tumor classification for cancers of the central nervous system (CNS).